DSC3 and neoplasm: When we further analysed the effect of methylation on clinical outcome by Kaplan–Meier analysis, we found that tumours with methylated DSC3 DNA were significantly correlated to a worse clinical outcome than unmethylated tumours (P=0.002, Figure 6).